ロード中...
Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras
Between December 2005 and October 2009, FDA approved six targeted therapies shown to significantly extend survival for advanced renal cell carcinoma (RCC) patients in clinical trials. This study aimed to examine changes in survival between the pretargeted and targeted therapy periods in advanced RCC...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4735783/ https://ncbi.nlm.nih.gov/pubmed/26645975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.574 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|